The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Injectable Drug Delivery Equipment Market Research Report 2024
Synopsis
Injectable Drug Delivery Equipment is a delivery equipment for injecting drugs from reagents to the human body. The increase in chronic diseases has led to an increased demand for these devices.
The global Injectable Drug Delivery Equipment market was valued at US$ 7450.2 million in 2023 and is anticipated to reach US$ 10430 million by 2030, witnessing a CAGR of 5.0% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Injectable Drug Delivery Equipment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Injectable Drug Delivery Equipment.
Report Scope
The Injectable Drug Delivery Equipment market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Injectable Drug Delivery Equipment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Injectable Drug Delivery Equipment manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer, Inc.
Baxter International, Inc.
Schott AG
Becton Dickinson
Terumo Corporation
Elcam Medical
Molex (Phillips-Medisize)
West Pharmaceutical Service
Biocorp
Haselmeier
SHL Group
Segment by Type
Conventional Drug Delivery
Novel Drug Delivery
Others
Segment by Application
Hospitals and Clinics
Homecare
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Injectable Drug Delivery Equipment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Injectable Drug Delivery Equipment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Injectable Drug Delivery Equipment is a delivery equipment for injecting drugs from reagents to the human body. The increase in chronic diseases has led to an increased demand for these devices.
The global Injectable Drug Delivery Equipment market was valued at US$ 7450.2 million in 2023 and is anticipated to reach US$ 10430 million by 2030, witnessing a CAGR of 5.0% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Injectable Drug Delivery Equipment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Injectable Drug Delivery Equipment.
Report Scope
The Injectable Drug Delivery Equipment market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Injectable Drug Delivery Equipment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Injectable Drug Delivery Equipment manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer, Inc.
Baxter International, Inc.
Schott AG
Becton Dickinson
Terumo Corporation
Elcam Medical
Molex (Phillips-Medisize)
West Pharmaceutical Service
Biocorp
Haselmeier
SHL Group
Segment by Type
Conventional Drug Delivery
Novel Drug Delivery
Others
Segment by Application
Hospitals and Clinics
Homecare
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Injectable Drug Delivery Equipment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Injectable Drug Delivery Equipment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Injectable Drug Delivery Equipment Market Overview
1.1 Product Overview and Scope of Injectable Drug Delivery Equipment
1.2 Injectable Drug Delivery Equipment Segment by Type
1.2.1 Global Injectable Drug Delivery Equipment Market Value Comparison by Type (2024-2030)
1.2.2 Conventional Drug Delivery
1.2.3 Novel Drug Delivery
1.2.4 Others
1.3 Injectable Drug Delivery Equipment Segment by Application
1.3.1 Global Injectable Drug Delivery Equipment Market Value by Application: (2024-2030)
1.3.2 Hospitals and Clinics
1.3.3 Homecare
1.3.4 Others
1.4 Global Injectable Drug Delivery Equipment Market Size Estimates and Forecasts
1.4.1 Global Injectable Drug Delivery Equipment Revenue 2019-2030
1.4.2 Global Injectable Drug Delivery Equipment Sales 2019-2030
1.4.3 Global Injectable Drug Delivery Equipment Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Injectable Drug Delivery Equipment Market Competition by Manufacturers
2.1 Global Injectable Drug Delivery Equipment Sales Market Share by Manufacturers (2019-2024)
2.2 Global Injectable Drug Delivery Equipment Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Injectable Drug Delivery Equipment Average Price by Manufacturers (2019-2024)
2.4 Global Injectable Drug Delivery Equipment Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Injectable Drug Delivery Equipment, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Injectable Drug Delivery Equipment, Product Type & Application
2.7 Injectable Drug Delivery Equipment Market Competitive Situation and Trends
2.7.1 Injectable Drug Delivery Equipment Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Injectable Drug Delivery Equipment Players Market Share by Revenue
2.7.3 Global Injectable Drug Delivery Equipment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Injectable Drug Delivery Equipment Retrospective Market Scenario by Region
3.1 Global Injectable Drug Delivery Equipment Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Injectable Drug Delivery Equipment Global Injectable Drug Delivery Equipment Sales by Region: 2019-2030
3.2.1 Global Injectable Drug Delivery Equipment Sales by Region: 2019-2024
3.2.2 Global Injectable Drug Delivery Equipment Sales by Region: 2025-2030
3.3 Global Injectable Drug Delivery Equipment Global Injectable Drug Delivery Equipment Revenue by Region: 2019-2030
3.3.1 Global Injectable Drug Delivery Equipment Revenue by Region: 2019-2024
3.3.2 Global Injectable Drug Delivery Equipment Revenue by Region: 2025-2030
3.4 North America Injectable Drug Delivery Equipment Market Facts & Figures by Country
3.4.1 North America Injectable Drug Delivery Equipment Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Injectable Drug Delivery Equipment Sales by Country (2019-2030)
3.4.3 North America Injectable Drug Delivery Equipment Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Injectable Drug Delivery Equipment Market Facts & Figures by Country
3.5.1 Europe Injectable Drug Delivery Equipment Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Injectable Drug Delivery Equipment Sales by Country (2019-2030)
3.5.3 Europe Injectable Drug Delivery Equipment Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Injectable Drug Delivery Equipment Market Facts & Figures by Country
3.6.1 Asia Pacific Injectable Drug Delivery Equipment Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Injectable Drug Delivery Equipment Sales by Country (2019-2030)
3.6.3 Asia Pacific Injectable Drug Delivery Equipment Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Injectable Drug Delivery Equipment Market Facts & Figures by Country
3.7.1 Latin America Injectable Drug Delivery Equipment Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Injectable Drug Delivery Equipment Sales by Country (2019-2030)
3.7.3 Latin America Injectable Drug Delivery Equipment Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Injectable Drug Delivery Equipment Market Facts & Figures by Country
3.8.1 Middle East and Africa Injectable Drug Delivery Equipment Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Injectable Drug Delivery Equipment Sales by Country (2019-2030)
3.8.3 Middle East and Africa Injectable Drug Delivery Equipment Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Injectable Drug Delivery Equipment Sales by Type (2019-2030)
4.1.1 Global Injectable Drug Delivery Equipment Sales by Type (2019-2024)
4.1.2 Global Injectable Drug Delivery Equipment Sales by Type (2025-2030)
4.1.3 Global Injectable Drug Delivery Equipment Sales Market Share by Type (2019-2030)
4.2 Global Injectable Drug Delivery Equipment Revenue by Type (2019-2030)
4.2.1 Global Injectable Drug Delivery Equipment Revenue by Type (2019-2024)
4.2.2 Global Injectable Drug Delivery Equipment Revenue by Type (2025-2030)
4.2.3 Global Injectable Drug Delivery Equipment Revenue Market Share by Type (2019-2030)
4.3 Global Injectable Drug Delivery Equipment Price by Type (2019-2030)
5 Segment by Application
5.1 Global Injectable Drug Delivery Equipment Sales by Application (2019-2030)
5.1.1 Global Injectable Drug Delivery Equipment Sales by Application (2019-2024)
5.1.2 Global Injectable Drug Delivery Equipment Sales by Application (2025-2030)
5.1.3 Global Injectable Drug Delivery Equipment Sales Market Share by Application (2019-2030)
5.2 Global Injectable Drug Delivery Equipment Revenue by Application (2019-2030)
5.2.1 Global Injectable Drug Delivery Equipment Revenue by Application (2019-2024)
5.2.2 Global Injectable Drug Delivery Equipment Revenue by Application (2025-2030)
5.2.3 Global Injectable Drug Delivery Equipment Revenue Market Share by Application (2019-2030)
5.3 Global Injectable Drug Delivery Equipment Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Pfizer, Inc.
6.1.1 Pfizer, Inc. Corporation Information
6.1.2 Pfizer, Inc. Description and Business Overview
6.1.3 Pfizer, Inc. Injectable Drug Delivery Equipment Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pfizer, Inc. Injectable Drug Delivery Equipment Product Portfolio
6.1.5 Pfizer, Inc. Recent Developments/Updates
6.2 Baxter International, Inc.
6.2.1 Baxter International, Inc. Corporation Information
6.2.2 Baxter International, Inc. Description and Business Overview
6.2.3 Baxter International, Inc. Injectable Drug Delivery Equipment Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Baxter International, Inc. Injectable Drug Delivery Equipment Product Portfolio
6.2.5 Baxter International, Inc. Recent Developments/Updates
6.3 Schott AG
6.3.1 Schott AG Corporation Information
6.3.2 Schott AG Description and Business Overview
6.3.3 Schott AG Injectable Drug Delivery Equipment Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Schott AG Injectable Drug Delivery Equipment Product Portfolio
6.3.5 Schott AG Recent Developments/Updates
6.4 Becton Dickinson
6.4.1 Becton Dickinson Corporation Information
6.4.2 Becton Dickinson Description and Business Overview
6.4.3 Becton Dickinson Injectable Drug Delivery Equipment Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Becton Dickinson Injectable Drug Delivery Equipment Product Portfolio
6.4.5 Becton Dickinson Recent Developments/Updates
6.5 Terumo Corporation
6.5.1 Terumo Corporation Corporation Information
6.5.2 Terumo Corporation Description and Business Overview
6.5.3 Terumo Corporation Injectable Drug Delivery Equipment Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Terumo Corporation Injectable Drug Delivery Equipment Product Portfolio
6.5.5 Terumo Corporation Recent Developments/Updates
6.6 Elcam Medical
6.6.1 Elcam Medical Corporation Information
6.6.2 Elcam Medical Description and Business Overview
6.6.3 Elcam Medical Injectable Drug Delivery Equipment Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Elcam Medical Injectable Drug Delivery Equipment Product Portfolio
6.6.5 Elcam Medical Recent Developments/Updates
6.7 Molex (Phillips-Medisize)
6.6.1 Molex (Phillips-Medisize) Corporation Information
6.6.2 Molex (Phillips-Medisize) Description and Business Overview
6.6.3 Molex (Phillips-Medisize) Injectable Drug Delivery Equipment Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Molex (Phillips-Medisize) Injectable Drug Delivery Equipment Product Portfolio
6.7.5 Molex (Phillips-Medisize) Recent Developments/Updates
6.8 West Pharmaceutical Service
6.8.1 West Pharmaceutical Service Corporation Information
6.8.2 West Pharmaceutical Service Description and Business Overview
6.8.3 West Pharmaceutical Service Injectable Drug Delivery Equipment Sales, Revenue and Gross Margin (2019-2024)
6.8.4 West Pharmaceutical Service Injectable Drug Delivery Equipment Product Portfolio
6.8.5 West Pharmaceutical Service Recent Developments/Updates
6.9 Biocorp
6.9.1 Biocorp Corporation Information
6.9.2 Biocorp Description and Business Overview
6.9.3 Biocorp Injectable Drug Delivery Equipment Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Biocorp Injectable Drug Delivery Equipment Product Portfolio
6.9.5 Biocorp Recent Developments/Updates
6.10 Haselmeier
6.10.1 Haselmeier Corporation Information
6.10.2 Haselmeier Description and Business Overview
6.10.3 Haselmeier Injectable Drug Delivery Equipment Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Haselmeier Injectable Drug Delivery Equipment Product Portfolio
6.10.5 Haselmeier Recent Developments/Updates
6.11 SHL Group
6.11.1 SHL Group Corporation Information
6.11.2 SHL Group Injectable Drug Delivery Equipment Description and Business Overview
6.11.3 SHL Group Injectable Drug Delivery Equipment Sales, Revenue and Gross Margin (2019-2024)
6.11.4 SHL Group Injectable Drug Delivery Equipment Product Portfolio
6.11.5 SHL Group Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Injectable Drug Delivery Equipment Industry Chain Analysis
7.2 Injectable Drug Delivery Equipment Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Injectable Drug Delivery Equipment Production Mode & Process
7.4 Injectable Drug Delivery Equipment Sales and Marketing
7.4.1 Injectable Drug Delivery Equipment Sales Channels
7.4.2 Injectable Drug Delivery Equipment Distributors
7.5 Injectable Drug Delivery Equipment Customers
8 Injectable Drug Delivery Equipment Market Dynamics
8.1 Injectable Drug Delivery Equipment Industry Trends
8.2 Injectable Drug Delivery Equipment Market Drivers
8.3 Injectable Drug Delivery Equipment Market Challenges
8.4 Injectable Drug Delivery Equipment Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
